The effect of psoriasis treatment with biologics on the efficacy of COVID-19 vaccines is largely unknown. Our study aimed to evaluate antibody response against SARS-CoV-2 following two doses of BNT162b2 (Pfizer/BioNTech vaccine) in patients with psoriasis receiving biologic monotherapy, and compare it with that of healthy controls.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538036 | PMC |
| http://dx.doi.org/10.1111/ced.15347 | DOI Listing |
Publication Analysis
Top Keywords
response sars-cov-2
8
vaccine patients
8
patients psoriasis
8
immune response
4
sars-cov-2 mrna
4
mrna vaccine
4
psoriasis treated
4
treated biologics
4
biologics psoriasis
4
psoriasis treatment
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!